Dow Down 0.18% Nasdaq Up 0.39%

RXi Pharmaceuticals Corporation (RXII)

-NasdaqCM
3.32 Up 0.34(11.41%) Sep 2, 4:00PM EDT
Prev Close:2.98
Open:3.00
Bid:3.25 x 700
Ask:3.97 x 300
1y Target Est:10.17
Beta:1.18
Next Earnings Date:N/A
Day's Range:2.96 - 3.52
52wk Range:2.21 - 6.84
Volume:1,390,070
Avg Vol (3m):187,438
Market Cap:53.46M
P/E (ttm):N/A
EPS (ttm):-1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RXII

Comparison

Symbol% ChgMkt Cap
RXIIUp 11.41%53.46M
AGNUp 1.69%49.47B
ALNYDown 1.72%5.23B
MRNADown 8.26%25.63M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):296.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.80
Quarterly EPS Est (Sep-14) :-0.23
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback